181 related articles for article (PubMed ID: 38190383)
1. Targeting osteopontin to treat primary sclerosing cholangitis.
De Muynck K; Devisscher L
Curr Opin Gastroenterol; 2024 Mar; 40(2):77-84. PubMed ID: 38190383
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
De Muynck K; Heyerick L; De Ponti FF; Vanderborght B; Meese T; Van Campenhout S; Baudonck L; Gijbels E; Rodrigues PM; Banales JM; Vesterhuus M; Folseraas T; Scott CL; Vinken M; Van der Linden M; Hoorens A; Van Dorpe J; Lefere S; Geerts A; Van Nieuwerburgh F; Verhelst X; Van Vlierberghe H; Devisscher L
Hepatology; 2024 Feb; 79(2):269-288. PubMed ID: 37535809
[TBL] [Abstract][Full Text] [Related]
3. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing cholangitis.
MacFaul GR; Chapman RW
Curr Opin Gastroenterol; 2005 May; 21(3):348-53. PubMed ID: 15818157
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing cholangitis.
MacFaul GR; Chapman RW
Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
7. An update on primary sclerosing cholangitis.
Maggs JR; Chapman RW
Curr Opin Gastroenterol; 2008 May; 24(3):377-83. PubMed ID: 18408468
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing cholangitis.
Maggs JR; Chapman RW
Curr Opin Gastroenterol; 2007 May; 23(3):310-6. PubMed ID: 17414848
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis: a clinical update.
Williamson KD; Chapman RW
Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
[TBL] [Abstract][Full Text] [Related]
10. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression.
Guillot A; Winkler M; Silva Afonso M; Aggarwal A; Lopez D; Berger H; Kohlhepp MS; Liu H; Özdirik B; Eschrich J; Ma J; Peiseler M; Heymann F; Pendem S; Mahadevan S; Gao B; Diehl L; Gupta R; Tacke F
Hepatology; 2023 Jul; 78(1):150-166. PubMed ID: 36630995
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis.
Chen YY; Arndtz K; Webb G; Corrigan M; Akiror S; Liaskou E; Woodward P; Adams DH; Weston CJ; Hirschfield GM
JHEP Rep; 2019 Nov; 1(5):369-376. PubMed ID: 32039388
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis and primary sclerosing cholangitis.
Angulo P; Lindor KD
Clin Liver Dis; 1999 Aug; 3(3):529-70. PubMed ID: 11291238
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
Kemme S; Mack CL
Pediatr Clin North Am; 2021 Dec; 68(6):1293-1307. PubMed ID: 34736590
[TBL] [Abstract][Full Text] [Related]
14. Medical and endoscopic treatment in primary sclerosing cholangitis.
Meier PN; Manns MP
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):657-66. PubMed ID: 11492974
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis.
Geonzon-Gonzales MR
Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
[TBL] [Abstract][Full Text] [Related]
16. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
Buckley SE; DiPalma JA
Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and management of primary sclerosing cholangitis.
Silveira MG; Lindor KD
World J Gastroenterol; 2008 Jun; 14(21):3338-49. PubMed ID: 18528931
[TBL] [Abstract][Full Text] [Related]
18. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases.
Sheng R; Zajko AB; Campbell WL; Abu-Elmagd K
AJR Am J Roentgenol; 1993 Aug; 161(2):297-300. PubMed ID: 8333366
[TBL] [Abstract][Full Text] [Related]
19. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases.
Dalekos GN; Gatselis NK
Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):197-211. PubMed ID: 31165900
[TBL] [Abstract][Full Text] [Related]
20. Secondary sclerosing cholangitis.
Ruemmele P; Hofstaedter F; Gelbmann CM
Nat Rev Gastroenterol Hepatol; 2009 May; 6(5):287-95. PubMed ID: 19404269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
